Udiong C E J, Udoh A E, Etukudoh M E
Department of Chemical Pathology, College of medical Sciences, University of Calabar, PMB 115, Calabar, Cross River State Nigeria.
Indian J Clin Biochem. 2007 Sep;22(2):74-8. doi: 10.1007/BF02913318.
The prevalence of abnormal thyroid hormone levels in diabetes mellitus in Nigeria is not well described. To determine the incidence of abnormal thyroid hormone levels in diabetics in Calabar, Nigeria, fasting blood samples from 161 diabetic subjects and 105 non-diabetic controls were analysed. Free thyroxine (FT), thyroid stimulating hormone (TSH), total triiodothyronine (T(3)) and total thyroxine (T(4)) kits obtained from Biomerica Inc. of USA were used for the analysis. TSH levels (1.80±1.62) in diabetics were significantly lower (p=0.016) than the level in non-diabetic controls (2.34±1.24). Male diabetics had lower (p<0.05) levels of TSH (1.192±0.68 miu/ml) than diabetic females (1.90±1.70 mlu/mt). The level of T(3) in diabetic males (125±97ng/ml) was higher than the level in females (98±75ng/dl). TSH (F=2.74, p=0.049), T(4)(F=56.87, p=0.001), T(3)(F=56.44, P=0.001) in diabetics and FT(4) (F=5.74, p=0.002) in controls showed significant variation with the ages of the subjects. Out of 161 diabetics subjects studies 26.6% had low plasma thyroid hormone levels (FT(4)>2.01 ng/dl). This study has shown a high incidence (46.5%) of abnormal thyroid hormone levels among the diabetics in Nigeria (hypothyroidism 26.6%, hyperthyroidism, 19.9%). The prevalence of hypothyroidism was higher in women (16.8%) than in men (9.9%), while hyperthyroidism was higher in males (11%) than in females (8%). This study has defined thyroid function status of diabetics in Calabar, Nigeria probably the first of such work in Africa.
尼日利亚糖尿病患者甲状腺激素水平异常的患病率尚无详尽描述。为确定尼日利亚卡拉巴尔糖尿病患者甲状腺激素水平异常的发生率,对161名糖尿病受试者和105名非糖尿病对照者的空腹血样进行了分析。使用从美国Biomerica公司获得的游离甲状腺素(FT)、促甲状腺激素(TSH)、总三碘甲状腺原氨酸(T₃)和总甲状腺素(T₄)检测试剂盒进行分析。糖尿病患者的TSH水平(1.80±1.62)显著低于非糖尿病对照者(2.34±1.24)(p = 0.016)。男性糖尿病患者的TSH水平(1.192±0.68 miu/ml)低于女性糖尿病患者(1.90±1.70 mlu/mt)(p<0.05)。糖尿病男性的T₃水平(125±97ng/ml)高于女性(98±75ng/dl)。糖尿病患者的TSH(F = 2.74,p = 0.049)、T₄(F = 56.87,p = 0.001)、T₃(F = 56.44,P = 0.001)以及对照者的FT₄(F = 5.74,p = 0.002)随受试者年龄呈现显著差异。在161名接受研究的糖尿病受试者中,26.6%的患者血浆甲状腺激素水平较低(FT₄>2.01 ng/dl)。该研究表明,尼日利亚糖尿病患者中甲状腺激素水平异常的发生率较高(46.5%)(甲状腺功能减退26.6%,甲状腺功能亢进19.9%)。甲状腺功能减退的患病率女性(16.8%)高于男性(9.9%),而甲状腺功能亢进的患病率男性(11%)高于女性(8%)。本研究明确了尼日利亚卡拉巴尔糖尿病患者的甲状腺功能状态,这可能是非洲此类研究中的首例。